These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25180281)

  • 21. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.
    Sirois PA; Montepiedra G; Kapetanovic S; Williams PL; Pearson DA; Malee K; Garvie PA; Kammerer BL; Nichols SL; Nozyce ML; Mintz M; Mitchell WG; Oleske JM;
    J Dev Behav Pediatr; 2009 Oct; 30(5):403-12. PubMed ID: 19827220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slowing of growth in height and weight on stimulants: a characteristic pattern.
    Poulton A; Cowell CT
    J Paediatr Child Health; 2003 Apr; 39(3):180-5. PubMed ID: 12654140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.
    Pliszka SR; Matthews TL; Braslow KJ; Watson MA
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):520-526. PubMed ID: 16670648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
    Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
    CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.
    Schoenfelder EN; Faraone SV; Kollins SH
    Pediatrics; 2014 Jun; 133(6):1070-80. PubMed ID: 24819571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study.
    Poulton AS; Armstrong B; Nanan RK
    CNS Drugs; 2018 Apr; 32(4):377-386. PubMed ID: 29557079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of baseline and post-concussion ImPACT test scores in young athletes with stimulant-treated and untreated ADHD.
    Gardner RM; Yengo-Kahn A; Bonfield CM; Solomon GS
    Phys Sportsmed; 2017 Feb; 45(1):1-10. PubMed ID: 27736285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Koonrungsesomboon K; Koonrungsesomboon N
    J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):189-197. PubMed ID: 31841645
    [No Abstract]   [Full Text] [Related]  

  • 34. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.
    Swanson JM; Arnold LE; Molina BSG; Sibley MH; Hechtman LT; Hinshaw SP; Abikoff HB; Stehli A; Owens EB; Mitchell JT; Nichols Q; Howard A; Greenhill LL; Hoza B; Newcorn JH; Jensen PS; Vitiello B; Wigal T; Epstein JN; Tamm L; Lakes KD; Waxmonsky J; Lerner M; Etcovitch J; Murray DW; Muenke M; Acosta MT; Arcos-Burgos M; Pelham WE; Kraemer HC;
    J Child Psychol Psychiatry; 2017 Jun; 58(6):663-678. PubMed ID: 28295312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.
    Sikirica V; Haim Erder M; Xie J; Macaulay D; Diener M; Hodgkins P; Wu EQ
    Pharmacoeconomics; 2012 Aug; 30(8):e1-15. PubMed ID: 22788263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT
    JAMA Netw Open; 2023 Jul; 6(7):e2322650. PubMed ID: 37432689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder].
    Zhang HY; Du ML; Zhuang SQ; Liu MN
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):723-7. PubMed ID: 16255846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV; Biederman J; Morley CP; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.